Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice

Abstract Background Atherosclerosis (AS) is a critical pathological event during the progression of cardiovascular diseases. It exhibits fibrofatty lesions on the arterial wall and lacks effective treatment. N6-methyladenosine (m6A) is the most common modification of eukaryotic RNA and plays an impo...

Full description

Bibliographic Details
Main Authors: Xinbin Zheng, Bo Zhou, Yuzhen Li, Hengren Zhong, Zhengxin Huang, Minhua Gu
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12864-023-09878-1
_version_ 1797388457225486336
author Xinbin Zheng
Bo Zhou
Yuzhen Li
Hengren Zhong
Zhengxin Huang
Minhua Gu
author_facet Xinbin Zheng
Bo Zhou
Yuzhen Li
Hengren Zhong
Zhengxin Huang
Minhua Gu
author_sort Xinbin Zheng
collection DOAJ
description Abstract Background Atherosclerosis (AS) is a critical pathological event during the progression of cardiovascular diseases. It exhibits fibrofatty lesions on the arterial wall and lacks effective treatment. N6-methyladenosine (m6A) is the most common modification of eukaryotic RNA and plays an important role in regulating the development and progression of cardiovascular diseases. However, the role of m6A modification in AS remains largely unknown. Therefore, in this study, we explored the transcriptome distribution of m6A modification in AS and its potential mechanism. Methods Methylation Quantification Kit was used to detect the global m6A levels in the aorta of AS mice. Western blot was used to analyze the protein level of methyltransferases. Methylated RNA immunoprecipitation with next-generation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) were used to obtain the first transcriptome range analysis of the m6A methylene map in the aorta of AS mice, followed by bioinformatics analysis. qRT-PCR and MeRIP-qRT-PCR were used to measure the mRNA and m6A levels in target genes. Results The global m6A and protein levels of methyltransferase METTL3 were significantly increased in the aorta of AS mice. However, the protein level of demethylase ALKBH5 was significantly decreased. Through MeRIP-seq, we obtained m6A methylation maps in AS and control mice. In total, 26,918 m6A peaks associated with 13,744 genes were detected in AS group, whereas 26,157 m6A peaks associated with 13,283 genes were detected in the control group. Peaks mainly appeared in the coding sequence (CDS) regions close to the stop codon with the RRACH motif. Moreover, functional enrichment analysis demonstrated that m6A-containing genes were significantly enriched in AS-relevant pathways. Interestingly, a negative correlation between m6A methylation abundance and gene expression level was found through the integrated analysis of MeRIP-seq and RNA-seq data. Among the m6A-modified genes, a hypo-methylated but up-regulated (hypo-up) gene Fabp5 may be a potential biomarker of AS. Conclusions Our study provides transcriptome-wide m6A methylation for the first time to determine the association between m6A modification and AS progression. Our study lays a foundation for further exploring the pathogenesis of AS and provides a new direction for the treatment of AS.
first_indexed 2024-03-08T22:41:05Z
format Article
id doaj.art-2679773597b24cb0ace487be568c275b
institution Directory Open Access Journal
issn 1471-2164
language English
last_indexed 2024-03-08T22:41:05Z
publishDate 2023-12-01
publisher BMC
record_format Article
series BMC Genomics
spelling doaj.art-2679773597b24cb0ace487be568c275b2023-12-17T12:07:54ZengBMCBMC Genomics1471-21642023-12-0124111110.1186/s12864-023-09878-1Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in miceXinbin Zheng0Bo Zhou1Yuzhen Li2Hengren Zhong3Zhengxin Huang4Minhua Gu5Clinical Research Center, Hainan Provincial Hospital of Traditional Chinese MedicineDepartment of Cardiology, Hainan Provincial Hospital of Traditional Chinese MedicineClinical Research Center, Hainan Provincial Hospital of Traditional Chinese MedicineClinical Research Center, Hainan Provincial Hospital of Traditional Chinese MedicineDepartment of Cardiology, Hainan Provincial Hospital of Traditional Chinese MedicineDepartment of Cardiology, Hainan Provincial Hospital of Traditional Chinese MedicineAbstract Background Atherosclerosis (AS) is a critical pathological event during the progression of cardiovascular diseases. It exhibits fibrofatty lesions on the arterial wall and lacks effective treatment. N6-methyladenosine (m6A) is the most common modification of eukaryotic RNA and plays an important role in regulating the development and progression of cardiovascular diseases. However, the role of m6A modification in AS remains largely unknown. Therefore, in this study, we explored the transcriptome distribution of m6A modification in AS and its potential mechanism. Methods Methylation Quantification Kit was used to detect the global m6A levels in the aorta of AS mice. Western blot was used to analyze the protein level of methyltransferases. Methylated RNA immunoprecipitation with next-generation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) were used to obtain the first transcriptome range analysis of the m6A methylene map in the aorta of AS mice, followed by bioinformatics analysis. qRT-PCR and MeRIP-qRT-PCR were used to measure the mRNA and m6A levels in target genes. Results The global m6A and protein levels of methyltransferase METTL3 were significantly increased in the aorta of AS mice. However, the protein level of demethylase ALKBH5 was significantly decreased. Through MeRIP-seq, we obtained m6A methylation maps in AS and control mice. In total, 26,918 m6A peaks associated with 13,744 genes were detected in AS group, whereas 26,157 m6A peaks associated with 13,283 genes were detected in the control group. Peaks mainly appeared in the coding sequence (CDS) regions close to the stop codon with the RRACH motif. Moreover, functional enrichment analysis demonstrated that m6A-containing genes were significantly enriched in AS-relevant pathways. Interestingly, a negative correlation between m6A methylation abundance and gene expression level was found through the integrated analysis of MeRIP-seq and RNA-seq data. Among the m6A-modified genes, a hypo-methylated but up-regulated (hypo-up) gene Fabp5 may be a potential biomarker of AS. Conclusions Our study provides transcriptome-wide m6A methylation for the first time to determine the association between m6A modification and AS progression. Our study lays a foundation for further exploring the pathogenesis of AS and provides a new direction for the treatment of AS.https://doi.org/10.1186/s12864-023-09878-1AtherosclerosisN6-methyladenosineMeRIP-seqFabp5
spellingShingle Xinbin Zheng
Bo Zhou
Yuzhen Li
Hengren Zhong
Zhengxin Huang
Minhua Gu
Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
BMC Genomics
Atherosclerosis
N6-methyladenosine
MeRIP-seq
Fabp5
title Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
title_full Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
title_fullStr Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
title_full_unstemmed Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
title_short Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
title_sort transcriptome wide n6 methyladenosine methylation profile of atherosclerosis in mice
topic Atherosclerosis
N6-methyladenosine
MeRIP-seq
Fabp5
url https://doi.org/10.1186/s12864-023-09878-1
work_keys_str_mv AT xinbinzheng transcriptomewiden6methyladenosinemethylationprofileofatherosclerosisinmice
AT bozhou transcriptomewiden6methyladenosinemethylationprofileofatherosclerosisinmice
AT yuzhenli transcriptomewiden6methyladenosinemethylationprofileofatherosclerosisinmice
AT hengrenzhong transcriptomewiden6methyladenosinemethylationprofileofatherosclerosisinmice
AT zhengxinhuang transcriptomewiden6methyladenosinemethylationprofileofatherosclerosisinmice
AT minhuagu transcriptomewiden6methyladenosinemethylationprofileofatherosclerosisinmice